Twitxy Saved

Yousuf Zafar, MD MHS

@yzafar

Oncologist. CMO @myAccessHope. Adjunct Professor @DukeMedSchool. Photographer.
Durham, NC yousufzafar.com Joined December 2007
608 Following 6.2K Followers 5K Posts

Latest posts 5

Yousuf Zafar, MD MHS @yzafar
I’m thrilled to join AccessHope as chief medical officer!

At AccessHope, our mission is clear: optimize patient outcomes & make cancer care more accessible and equitable for all. I’m deeply honored to join this incredible team, which keeps patients at the heart of every decision
AccessHope @myaccesshope Nov 13, 2024
We’re thrilled to announce that renowned oncologist @yzafar, M.D., MHS has joined as our new chief medical officer and digital health veteran @peterbridges has joined as our chief strategy and growth officer. Debra Morris, our COO/CFO has also been promoted to president.
myaccesshope.org/press-releases…
View quoted post on X
7 replies 3 reposts 31 likes 5.5K views View on X
Yousuf Zafar, MD MHS @yzafar
Deciding between adjuvant therapy yes/no for stage II #coloncancer?

Check out @gabe_a_brooks great summary. I would only add this: patient preference plays a role, of course #ASCO22
Gabriel Brooks @gabe_a_brooks Jun 7, 2022
My preliminary takeaways re: DYNAMIC:

In stage 2 colon cancer, only three biomarkers are ultimately useful for selecting adjuvant therapy candidates after R0 resection. They are:

T4
dMMR
ctDNA positivity (provisional)

1/4 #ASCO22
View quoted post on X
Yousuf Zafar, MD MHS @yzafar
You know it’s big news when my mom in Ohio called me about this study. Congratulations to @AndreaCercek and team for a huge result for the benefit of our patients #ASCO22
Andrea Cercek @AndreaCercek Jun 5, 2022
Very proud of our study published in @NEJM. 100% clinical complete response with dostarlimab alone in mismatch repair-deficient locally advanced #RectalCancer. No radiation or surgery! @ASCO #ASCO22 @MSKCancerCenter nejm.org/doi/full/10.10…
View quoted post on X